Gain Therapeutics Inc. (GANX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
1. 26
-0.07
-5.2632%
$
69.95M Market Cap
- P/E Ratio
- Div Yield
464,400 Volume
-1.19 Eps
$ 1.33
Previous Close Want to track GANX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Gain Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 58,456 | $102,298 | $77,161.92 | -$25,136.08 | -24.57% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 10,745 | $18,803.75 | $14,183.4 | -$4,620.35 | -24.57% |
 David Einhorn Greenlight Capital Re Ltd. | 588,410 | $8.29M | $735,512.5 | -$7.56M | -91.13% |
 W. Travis McKinney HB Wealth Management LLC | 12,783 | $22,370.25 | $17,001.39 | -$5,368.86 | -24% |
| MFA Millington Financial Advisors LLC Millington Financial Advisors LLC | 15,000 | $29,250 | $19,425 | -$9,825 | -33.59% |
 Hui Fai Tam Caitong International Asset Management Co. Ltd. | 165 | $288.75 | $219.45 | -$69.3 | -24% |
2026 © Marketlog. All Rights Reserved.
